Concepedia

Author

Masaki Hiraoka

Bristol-Myers Squibb (Germany)ORCID

Also Known As

M Hiraoka, M. Hiraoka, MASAKI HIRAOKA, Masaki HIRAOKA, Masaki Hiraoka

31

Publications

381

Citations

12

H-Index

41

Concepts

All Affiliations

Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (Japan)Gunma University
MH

About

Masaki Hiraoka is an author at Bristol-Myers Squibb (Germany) specializing in medicine, pharmacology, and drug resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

168

2

Health Sciences

2

2

31

3

Biochemistry

1

1

19

4

Cell Biology

1

1

35

5

Immunology

1

1

27

Masaki Hiraoka

×

14

Publications

303

Citations

11

H-Index

YearCitations

Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of apixaban in healthy Japanese male subjects

Naomi Yamahira, Charles Frost, Hiroyuki Fukase,

International Journal of Clinical Pharmacology and Therapeutics

2014

42

Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor

H Nakagawa, Toshiaki Fujita, Shigeki Kubo,

Cancer Chemotherapy and Pharmacology

1996

40

Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.

Masaki Hiraoka, SHINJI MASUYOSHI, Susumu Mitsuhashi,

The Journal of Antibiotics

1988

37

Comparison between tumor pH and cell sensitivity to heat in RIF-1 tumors.

Masaki Hiraoka, George M. Hahn

PubMed

1989

35

MUTAGENICITY TESTS OF ETOPOSIDE AND TENIPOSIDE

H Nakanomyo, Masaki Hiraoka, Mayumi SHIRAYA

The Journal of Toxicological Sciences

1986

27

Hydrolytic Rate at Low Drug Concentration as a Limiting Factor in Resistance to Newer Cephalosporins

Masaki Hiraoka, Manabu Inoue, S Mitsuhashi

Clinical Infectious Diseases

1988

21

Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli

Masaki Hiraoka, R Okamoto, Manabu Inoue,

Antimicrobial Agents and Chemotherapy

1989

19

Model-based determination of abatacept exposure in support of the recommended dose for Japanese rheumatoid arthritis patients

Mayumi Hasegawa, Yasuhiko Imai, Masaki Hiraoka,

Journal of Pharmacokinetics and Pharmacodynamics

2011

13

Pharmacokinetics of Weekly Paclitaxel and Feasibility of Dexamethasone Taper in Japanese Patients with Advanced Non–small Cell Lung Cancer

Hiroshi Nokihara, Noboru Yamamoto, Yuichiro Ohe,

Clinical Therapeutics

2016

13

Enantioselective determination of sotalol enantiomers in biological fluids using high-performance liquid chromatography

T. Shimizu, Masaki Hiraoka, H Nakanomyo

Journal of Chromatography B Biomedical Sciences and Applications

1995

12

Page 1